Onderneming Ventrus Biosciences Inc Nasdaq
Aandelen
US9228221019
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- USD | - |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Novel Therapeutics
100,0
%
| 0 | nan % | 7 | 100,0 % | - |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 7 | 100,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jason Okazaki
CEO | Chief Executive Officer | 48 | 30-03-20 |
Anuj Gaggar
CTO | Chief Tech/Sci/R&D Officer | 46 | 08/11 |
William Delaney
CTO | Chief Tech/Sci/R&D Officer | 52 | 01-06-20 |
John McHutchison
BRD | Director/Board Member | 66 | 06-08-19 |
Shannon Ryan
IRC | Investor Relations Contact | - | - |
Comptroller/Controller/Auditor | - | 01-08-19 | |
General Counsel | - | 01-09-22 | |
Nicole White
PRN | Corporate Officer/Principal | 44 | 17-11-20 |
Human Resources Officer | - | 01-05-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Susan Mahony
BRD | Director/Board Member | 59 | 14-12-17 |
Gina Consylman
BRD | Director/Board Member | 52 | 20-10-20 |
William Ringo
CHM | Chairman | 78 | 01-07-14 |
Anthony Altig
BRD | Director/Board Member | 68 | 01-01-12 |
Jason Okazaki
CEO | Chief Executive Officer | 48 | 30-03-20 |
Michael Houghton
BRD | Director/Board Member | 73 | 19-07-21 |
John McHutchison
BRD | Director/Board Member | 66 | 06-08-19 |
Tomas Cihlar
BRD | Director/Board Member | 57 | 07/12 |
Director/Board Member | 60 | 20-05-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 5 513 308 | 3 690 474 ( 66,94 %) | 0 | 66,94 % |
Bedrijfsgegevens
Assembly Biosciences, Inc.
Two Tower Place 7th floor
94080, South San Francisco
+833 509 4583
http://www.assemblybio.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+14,16% | 74,45 mld. | |
+11,35% | 9,18 mld. | |
+60,16% | 5,03 mld. | |
-12,85% | 5,02 mld. | |
+1,60% | 3,82 mld. | |
-19,20% | 2,41 mld. | |
+19,07% | 2,39 mld. | |
-27,46% | 2,27 mld. | |
+24,62% | 2,26 mld. |
- Beurs
- Aandelen
- Koers ASMB
- Koers
- Onderneming Ventrus Biosciences Inc